Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
AI channel feed
Cash, chips and talent: Inside Nvidia's plan to dominate biotech's AI revolution
Last year
R&D
In Focus
Exclusive: Ex-Recursion team launches Leash Bio, challenging AI field with its bet on needing more data
Last year
Financing
ARPA-H calls on AI developers to help tackle cyberattacks
Last year
FDA+
Health Tech
Exclusive: ‘If you could hallucinate a protein’: Profluent snags $35M for generative AI models
Last year
Financing
Startups
David Baker’s lab shows generative AI can design antibodies. But are they good enough to become drugs?
Last year
R&D
‘An AI foundry’: Nvidia’s Jensen Huang pitches biotech on easy AI, with focus on software going beyond chips
Last year
Novo Nordisk Foundation backs effort to build supercomputer with Nvidia
Last year
R&D
FDA lays out cross-agency efforts on regulating AI in medical products
Last year
Pharma
FDA+
Exclusive: ‘ChatGPT for DNA’: Relation nabs $35M, with Nvidia backing, for osteoporosis work
Last year
Financing
Startups
David Baker's lab releases new protein design and study tools as AI race accelerates
Last year
R&D
Discovery
Health tech investors outline investment priorities in AI
Last year
Health Tech
Biden administration invests $48M in AI/ML platform to identify rare disease drugs
Last year
Pharma
FDA+
Owkin launches new startup to ‘capture laws of biology’ with $35M seed round
Last year
Financing
Startups
Correction: Iambic says new AI model bests AlphaFold as protein models rocket ahead
Last year
R&D
FDA to modernize drug surveillance internally with use of AI
Last year
FDA+
Schrödinger takes a step forward with AlphaFold in drug R&D, as biotech hits a pipeline 'inflection'
Last year
R&D
Creative AI gains steam among pharma marketers including Sanofi, Novartis, although concerns abound
Last year
Pharma
Marketing
#JPM24 quick hits: Vibe check; Maze’s next turn; AI at pharma companies + more
Last year
Deals
Pharma
Exclusive: Alphabet's Isomorphic inks first pharma deals with Eli Lilly and Novartis for $83M upfront, $2.9B in milestones
Last year
Startups
Deals
Former execs from Pfizer obesity drug program have started a new biotech with $52M from VC fund ATP
Last year
Financing
Startups
Exclusive: Aviv Regev talks three years of leading Genentech’s research, the future of AI, and not making Nobel predictions
Last year
People
R&D
Aviv Regev leads Genentech's next revolution with AI
Last year
R&D
In Focus
Sanofi forms drug discovery pact with French startup Aqemia en route to ‘AI at scale’ ambition
Last year
Startups
Deals
UCSF scientists aim to unravel autism with brain organoids and AI
Last year
R&D
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page